Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction (Q42523851)

1 November 2017

title

Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction (English)

1 reference

1 November 2017

0 references

myocardial infarction

1 reference

1 reference

Kathryn Bates

1

1 reference

1 November 2017

Charles E Ruggeroli

series ordinal

2

1 reference

1 November 2017

Steven Goldman

series ordinal

3

1 reference

1 November 2017

Mohamed A Gaballa

series ordinal

4

1 reference

1 November 2017

publication date

1 August 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

1 November 2017

published in

1 reference

1 November 2017

volume

283

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

H768-75

1 reference

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Gene transfer of endothelial nitric oxide isoform decreases rat hindlimb vascular resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Large artery remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Biosynthesis and metabolism of endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Oxidative stress contributes to vascular endothelial dysfunction in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Restricted diffusion of macromolecules by endothelial monolayers and small-pore filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00826.2001

10.1152/AJPHEART.00826.2001

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference